Newsfeeds Archive - Page 19054 of 19074

1 minute read

This Biopharmaceutical Company Has A Better 1-Year Return Than Tesla, Apple, Starbucks, Nvidia And Microsoft

July 1, 10:45 AM

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) creates new possibilities via medicine to cure diseases and improve people's lives, and over the past year, marked gains in investors’ portfolios.

AAPL

2 minute read

Labor Market Is Tight Yet Layoffs Surge As Tesla, Coinbase, Netflix And Others Cut Staff

By AJ Fabino

July 1, 10:35 AM

The recent unemployment claims numbers confirm the Federal Reserve's assertion that the labor market is tight. However, layoffs are intensifying, particularly in the tech and cryptocurrency sectors.

COIN

2 minute read

This Is What Whales Are Betting On Freeport-McMoRan

By Benzinga Insights

July 1, 10:34 AM

Someone with a lot of money to spend has taken a bearish stance on Freeport-McMoRan (NYSE:FCX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

FCX

1 minute read

CNBC’s Final Trades: Cleveland-Cliffs, McKesson And These Defensive Plays

By Priya Nigam

July 1, 10:33 AM

On CNBC’s “Halftime Report Final Trades,” Jon Najarian said that Cleveland-Cliffs Inc’s (NYSE: CLF) stock had declined more than 30% in a month. “I like it.

CLF

2 minute read

Exxon Mobil Whale Trades For July 01

By Benzinga Insights

July 1, 10:33 AM

A whale with a lot of money to spend has taken a noticeably bearish stance on Exxon Mobil. Looking at options history for Exxon Mobil (NYSE:XOM) we detected 15 strange trades.

XOM

1 minute read

News

‘Tesla Already Planning Huge Giga Texas Expansion: Permits Filed’ – InsideEVs

By Benzinga Newsdesk

July 1, 10:32 AM

https://insideevs.com/news/595647/tesla-gigafactory-texas-massive-expansion-permits/amp/

TSLA

2 minute read

What Are Whales Doing With Chevron

By Benzinga Insights

July 1, 10:31 AM

Someone with a lot of money to spend has taken a bearish stance on Chevron (NYSE:CVX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

CVX

1 minute read

Takeda’s Hereditary Angioedema Treatment Prevents Attacks In Kids Below 12 Years

By Vandana Singh

July 1, 10:28 AM

Takeda Pharmaceutical Co Ltd (NYSE: TAK) announced late-breaking data from the Phase 3 SPRING study presented at the European Academy of Allergy and Clinical Immunology Hybrid Congress 2022.

TAK

1 minute read

Analyst Ratings

Where Amphenol Stands With Analysts

By Benzinga Insights

July 1, 10:28 AM

Amphenol (NYSE:APH) has observed the following analyst ratings within the last quarter:

APH

2 minute read

Analyst Ratings

10 Analysts Have This to Say About Accolade

By Benzinga Insights

July 1, 10:27 AM

Over the past 3 months, 10 analysts have published their opinion on Accolade (NASDAQ:ACCD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

ACCD